Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension

Journal of the American College of Cardiology

Volumn 28, Issue 4, 1996, Pages 964-971

  Testa, Marco ^a   Yeh, Michael ^a   Lee, Paul ^a   Fanelli, Raffaele ^b   Loperfido, Francesco ^b   Berman, Joan W ^a   LeJemtel, Thierry H ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIAC GLYCOSIDE; CARDIOVASCULAR AGENT; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LOOP DIURETIC AGENT; NITRIC ACID DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; CONGESTIVE HEART FAILURE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL ASSESSMENT; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; IMMUNOMODULATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

EID: 0030273548     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(96)00268-9     Document Type: Article

References (22)

1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990;323:236-41.
2. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumor necrosis in cachetic patients with severe chronic heart failure. Br Heart J 1991;66:356-8.
3. Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK. Tumour necrosis factor α in severe congestive cardiac failure. Br Heart J 1993;70:141-3.
4. Wiedermann CJ, Beimpold H, Herold M, Knapp E, Braunsteiner H. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. J Am Coll Cardiol 1993;22:1987-90.
5. Packer M. Is tumor necrosis factor an important neurohormonal mechanism in chronic heart failure? Circulation 1995;92:1379-82.
6. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J 1994;72:561-6.
7. Katz SD, Rao R, Berman JW, et al. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure: relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation 1994;90:12-6.
8. Limas CJ, Golderberg IF, Limas C. Soluble interleukin-2 receptor levels in patients with dilated cardiomyopathy: correlation with disease severity and cardiac autoantibodies. Circulation 1995;91:631-4.
9. Torre-Amione G, Kapadia S, Benedict C, Oral H, Young JB, Mann DL. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the Studies of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 1996;27:1201-6.
10. Ferrari R, Bachetti T, Confortini R, et al. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation 1995;92:1479-86.
11. Ansari A. Syndromes of cardiac cachexia and the cachectic heart: current perspective. Prog Cardiovasc Dis. 30:1987;45-60.
12. Holzinger C, Schollhammer A, Imhof M, et al. Phenotypic patterns of mononuclear cells in dilated cardiomyopathy. Circulation 1995;92:2876-85.
13. Hwang S, Harris TJ, Wilson NW, Maisel AS. Immune function in patients with chronic stable congestive heart failure. Am Heart J 1993;125:1651-8.
14. Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor-α gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest 1995;96:1042-52.
15. Mann DL, Lee-Jackson D, Yokoyama T. Tumor necrosis factor alpha and cardiac remodeling. Heart Failure 1995;11:166-76.
16. Vaddi K, Nicolini FA, Mehta P, Mehta JL. Increased secretion of tumor necrosis factor α and interferon γ by mononuclear leukocytes in patients with ischemic heart disease: relevance in superoxide anion generation. Circulation 1994;90:694-9.
17. Neumann FJ, Ott I, Gawaz M, et al. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 1995;92:748-55.
18. Kapadia S, Torre-Amione G, Mann DL Pitfalls in measuring cytokines [letter]. Ann Intern Med. 121:1994;149-500.
19. Porteu F, Hieblot C. Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. J Bio Chem 1994;269:2834-40.
20. Honda M, Yamamoto S, Cheng M, et al. Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J Immunol 1992;148:2175-80.
21. DeBenedetti F, Massa M, Pignatti P, Albani S, Novick D, Martini A. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest 1994;93:2114-9.
22. Fireling JTM, van Deuren M, Wijdenes J. Circulating interleukin-6 receptor in patients with sepsis syndrome. J Infect Dis 1995;171:469-72.